The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

People with type 1 diabetes risk getting kidney disease if they engage in so-called yo-yo dieting, a team of French doctors warns.The danger applies regardless of a patient's weight or other ...

A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with metabolic syndrome who received daily metformin with or without a Mediterranean ...

"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns.

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...

Trusted source of information on diabetes that includes articles, news, videos, animations, quizzes, calculators and drugs.

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other ...

Celebrities like Jessica Simpson, Adele, and Jennifer Hudson have shared their inspiring weight loss journeys, proving that major transformations are possible with the right mindset and approach. What ...